Skip to content

â??EFFECTS OF PERIODONTAL THERAPY IN PATIENTS WITH TYPE II DIABETETS MELLITUS AND CHRONIC PERIODONTITISâ??

â??EFFECTS OF NON SURGICAL PERIODONTAL THERAPY ON INSULIN RESISTANCE IN PATIENTS WITH TYPE II DIABETETS MELLITUS AND CHRONIC PERIODONTITISâ??- A CLINICAL TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/10/004051
Enrollment
40
Registered
2013-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with type II diabetes mellitus and chronic periodontitis

Interventions

Sponsors

Dr Jerry Mammen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with age group between 30 to 50. 2. Minimum of 20 teeth present. 3. Patients who were diagnosed with severe periodontitis chronic periodontitis (CDC criteria moderate periodontitis is defind as >=2 interproximal sites with >= 4mm clinical attacment loss (CAL) not on same tooth,or >=2 interproximal with probing depth (PD) >= 5mm not on same tooth severe periodontitis is defind as >=2 teeth with clinical attachment loss >=6mm not on same tooth and >=1 interproximal site with probing depth >= 5mm). 4. Patients diagnosed with type II diabetes mellitus(moderately poor glycemic control, HbA1c between7% and 10%), on oral hypoglycemic drugs and dietary modification only

Exclusion criteria

Exclusion criteria: 1.Patients with known systemic disease and condition, other than type II diabetes mellitus such as CVD, renal disease, RA, , liver and pancreatic disease, nutritional deficiencies, pregnant and lactating mother. 2. Patients with acute condition that contraindicate a periodontal examination. 3. Patients who received systemic antibiotic therapy within past 6 month. 4. Patients who received periodontal therapy (scaling and root planing or surgery) past 1 year. 5. Smokers and smokeless tobacco users 6. Patients not willing to sign informed consent

Design outcomes

Primary

MeasureTime frame
insulin resistanceTimepoint: three months

Secondary

MeasureTime frame
Glycemic control Timepoint: three months

Countries

India

Contacts

Public ContactDr Rosamma Joseph V

Government dental college, Kozhikode

drrosammajoseph@gmail.com09446070599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026